FDA Approves Amgen’s Heart-Failure Drug Corlanor

  (USA Today) – The U.S. Food and Drug Administration on Wednesday approved Amgen Inc.’s heart-failure treatment Corlanor, which had been designated for priority review in August. The drug is an oral medication intended to regulate heart rate and reduce the risk of hospitalization for worsening heart Read More